Evercore ISI Removes Krystal Biotech (KRYS) From Tactical Outperform List
Evercore ISI analyst Josh Schimmer reiterated an Outperform rating and $168.00 price target on Krystal Biotech (NASDAQ: KRYS)
- Removes from Tactical Outperform List.
For an analyst ratings summary and ratings history on Krystal Biotech click here. For more ratings news on Krystal Biotech click here.
Shares of Krystal Biotech closed at $111.33 yesterday.